Category Health/Medical

The FDA granted its first emergency authorization for a rapid antibody blood test for COVID-19, developed by Cellex, allowing people to gauge a person’s immune response to the novel coronavirus.

The serological test—which uses a fingerprick of blood and a small strip, similar to a combination of a blood glucose test and a home pregnancy exam—detects two different types of antibodies produced by the body to fight off the infection. Available by prescription, this can be used to determine whether a person has been previously infected and possibly recovered.

An international team led by University of British Columbia researcher Dr. Josef Penninger has found a trial drug that effectively blocks the cellular door SARS-CoV-2 uses to infect its hosts.

The findings, published today in Cell, hold promise as a treatment capable of stopping early infection of the novel coronavirus that, as of April 2, has affected more than 981,000 people and claimed the lives of 50,000 people worldwide.

The study provides new insights into key aspects of SARS-CoV-2, the virus that causes COVID-19, and its interactions on a cellular level, as well as how the virus can infect blood vessels and kidneys.

“We are hopefu...

Ethanol from agave could be used for transport fuel and hand sanitizer. The agave plant used to make tequila could be established in semi-arid Australia as an environmentally friendly solution to Australia’s transport fuel shortage, a team of researchers at the University of Sydney, University of Exeter and University of Adelaide has found.

The efficient, low-water process could also help produce ethanol for hand sanitiser, which is in high demand during the COVID-19 pandemic.

In an article published this week in the Journal of Cleaner Production, University of Sydney agronomist Associate Professor Daniel Tan with international and Australian colleagues have analysed the potential to produce bioethanol (...

Researchers at Karolinska Institutet and St Erik Eye Hospital in Sweden have discovered a way to refine the production of retinal cells from embryonic stem cells for treating blindness in the elderly. Using the CRISPR/Cas9 gene editing, they have also managed to modify the cells so that they can hide from the immune system to prevent rejection. The studies are published in the scientific journals Nature Communications and Stem Cell Reports.

Age-related macular degeneration of the eye is the most common cause of blindness in the elderly...